Skip to main content

Mersana Therapeutics, Inc.

MRSNDelisted Jan 6, 2026
Industry
Pharmaceutical Preparations
SEC CIK
0001442836

Mersana Therapeutics, Inc. was delisted on Jan 6, 2026; its insiders filed their last Form 4 on Jan 6, 2026; 51 institutions reported holding it in 13F filings for Q4 2025, worth $64.8M in total; no superinvestor held it.

Q2 2021 vs. Q1 2021

How the institutions holding Mersana Therapeutics, Inc. changed between Q1 2021 and Q2 2021.

All holders in Q2 2021All holders in Q1 2021

13F holders of MRSN: Q1 2021 compared with Q2 2021
MeasureQ1 2021Q2 2021Change
Holders132131−1
Shares70.1M70.6M+496.4K (+0.7%)
Value$1.14B$957.8M−$186.5M (−16.3%)

New holders (18)

Institutions that held Mersana Therapeutics, Inc. at the end of Q2 2021 but not at the end of Q1 2021.

Institutions new to MRSN in Q2 2021
InstitutionSharesValue% of portfolio
Assenagon Asset Management S.A.1,040,942$14.1M0.06%
Maven Securities LTD84,469$1.17M0.12%
Hudson Bay Capital Management LP70,000$951.0K0.01%
Qube Research & Technologies Ltd62,685$851.0K0.01%
HighVista Strategies LLC59,906$814.0K0.58%
Walleye Capital LLC38,815$527.0K0.02%
Skandinaviska Enskilda Banken AB (publ)30,304$412.0K0.00%
Twinbeech Capital LP21,570$293.0K0.04%
ExodusPoint Capital Management, LP21,147$287.0K0.00%
Dynamic Technology Lab Private Ltd19,821$269.0K0.03%
Quantbot Technologies LP16,200$219.0K0.02%
Boothbay Fund Management, LLC16,071$218.0K0.01%
Walleye Trading LLC15,200$206.0K0.01%
XTX Topco Ltd14,541$197.0K0.07%
Amalgamated Bank12,021$163.0K0.00%
Bridgefront Capital, LLC11,236$153.0K0.06%
Tudor Investment Corp Et Al10,449$142.0K0.00%
Dark Forest Capital Management LP607$8.00K0.00%

Sold out (19)

Institutions that held Mersana Therapeutics, Inc. at the end of Q1 2021 and filed for Q2 2021 without it.